New-onset atrial fibrillation (NOAF) frequently complicates acute coronary syndromes (ACS) leading to adverse short and long-term outcomes. The reported incidence ranges from 4 to 22% and a number of factors have consistently been shown to be associated with NOAF.
To determine the incidence of NOAF in a Tunisian population admitted for ACS, and to identify its predictive factors.
We performed a prospective observational cohort study including consecutive patients admitted to a single center for ACS over a one-year period. According to the NOAF occurred during hospitalization, the patients were divided into two groups: the NOAF and the non-NOAF group.
We included 402 patients. The incidence of NOAF was 9.7% in ACS Tunisian patients. NOAF was more frequent in older patients (P=0.001) and in those with previous renal failure (P<0.001), stroke (P=0.009) and ischemic cardiomyopathy (P=0.02). During hospitalization, patients with NOAF more often had heart failure (P=0.01) and higher values of serum uric acid (P=0.001), peak creatinine (P=0.001), CRP (P=0.02), neutrophil to lymphocyte ratio (P=0.04) and mean platelet volume (MPV, P=0.02). On echocardiography, they had greater indexed left atrial volume (P=0.02) and systolic arterial pulmonary pressure (P=0.03) while left ventricular ejection fraction (LVEF: 43±12% vs 48±10%, P=0.01) was significantly lower. Hemoglobin (119±1.8g/l vs 130±1.9g/l, P=0.001) was significantly lower in the NOAF group than the non-NOAF group. There were no significant differences in history of hypertension, diabetes, heart failure or pulmonary disease. In multivariate analysis, age (OR=1.08; P=0.02), MPV (OR=1.4; P=0.03), LVEF (OR=2; P=0.001) and indexed left atrial volume (OR=1.15; P=0.004) remained independent predictors of NOAF.
Age, LVEF, MPV and indexed left atrial volume are risk factors for incident NOAF in Tunisian patients admitted for ACS.
Le texte complet de cet article est disponible en PDF.
Publié par Elsevier Masson SAS.